4.65 DESTINY BREAST 04 - A complex trial to deconstruct - a podcast by Vinay Prasad, MD MPH

My take on the standing ovation for DESTINY Breast 04
Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low

Further episodes of Plenary Session

Further podcasts by Vinay Prasad, MD MPH

Website of Vinay Prasad, MD MPH